- Working from Home? Here’s How to Preserve Your Posture
- FDA Approves Third COVID Vaccine
- FDA Set to Approve Third COVID Vaccine
- Spring Allergies Are Near, Here’s What Works to Fight Them
- Education Level Now Prime Driver of COVID Vaccine Hesitancy: Poll
- Rheumatoid Arthritis Meds May Help Fight Severe COVID-19
- AHA News: From Mild COVID-19 to Heart Failure in 4 Weeks – at Age 20
- In Israel, Widespread Vaccination Slashes Severe COVID Cases in Older Patients
- Mental Health ‘Epidemic’ Threatens Communities of Color Amid COVID-19
- Expert Panel Set to Consider Approval of J&J COVID Vaccine
Clinical Trials Update: May 11, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Asthma
This study is evaluating an investigational medication for asthma. You may qualify if you are 18 or older and have been diagnosed with asthma.
The research study is in Venice, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/asthma.aspx.
—–
Crohn’s Disease
To qualify for this study, you must have Crohn’s disease symptoms at least three months prior to the first clinic visit and have a confirmed diagnosis of Crohn’s by MRI, x-ray, or endoscopy.
The research site is in Houston, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/crohn’s_disease.aspx.
—–
Fibromyalgia
This study of an investigational drug is for people who have pain associated with fibromyalgia.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/fibromyalgia.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
